Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain

J Cell Biol. 2005 May 23;169(4):577-89. doi: 10.1083/jcb.200412101. Epub 2005 May 16.

Abstract

Timely differentiation of progenitor cells is critical for development. In this study we asked whether global epigenetic mechanisms regulate timing of progenitor cell differentiation into myelin-forming oligodendrocytes in vivo. Histone deacetylation was essential during a specific temporal window of development and was dependent on the enzymatic activity of histone deacetylases, whose expression was detected in the developing corpus callosum. During the first 10 postnatal days, administration of valproic acid (VPA), the specific inhibitor for histone deacetylase activity, resulted in significant hypomyelination with delayed expression of late differentiation markers and retained expression of progenitor markers. Differentiation resumed in VPA-injected rats if a recovery period was allowed. Administration of VPA after myelination onset had no effect on myelin gene expression and was consistent with changes of nucleosomal histones from reversible deacetylation to more stable methylation and chromatin compaction. Together, these data identify global modifications of nucleosomal histones critical for timing of oligodendrocyte differentiation and myelination in the developing corpus callosum.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylation
  • Animals
  • Animals, Newborn
  • Biomarkers / metabolism
  • Brain / cytology
  • Brain / growth & development*
  • Brain / metabolism*
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology*
  • DNA Methylation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Epigenesis, Genetic / physiology
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Expression Regulation, Developmental / physiology
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases / metabolism
  • Histones / metabolism*
  • Myelin Sheath / drug effects
  • Myelin Sheath / genetics
  • Myelin Sheath / metabolism
  • Nucleosomes / drug effects
  • Nucleosomes / genetics
  • Nucleosomes / metabolism
  • Oligodendroglia / cytology
  • Oligodendroglia / drug effects
  • Oligodendroglia / metabolism*
  • Rats
  • Stem Cells / cytology
  • Stem Cells / drug effects
  • Stem Cells / metabolism*
  • Valproic Acid / pharmacology

Substances

  • Biomarkers
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Histones
  • Nucleosomes
  • Valproic Acid
  • Histone Deacetylases